News

Watch the new video on how working with European Life Science Research Infrastructures can advance your research project. EU-OPENSCREEN is part of the European Research Infrastructure landscape and…

Fundación MEDINA, Almirall, S.A. (ALM) and the University Carlos III Madrid (UC3M) have launched a project to find new treatments for recessive dystrophic epidermolysis bullosa and other genetic…

How can researchers in the Baltic region work with EU-OPENSCREEN and our partner sites and collaboratively develop novel chemical probes? How can chemists make their compounds available to other…

Mabel Loza from the BioFarma Group of our partner site, University of Santiago de Compostela, received the Wonenburger Award 2019. The Wonenburger Prize was created in memorian of María Josefa…

Our partners sites have submitted their proposals within the first call (year 2020) of the EU-OPENSCREEN ERIC training activities, presenting their plans for training courses they would like to…

May 6, 2020, was a great day for EU-OPENSCREEN: We received our state-of-the-art automated tube store. The tube store will be at the heart of our new compound management facility at our central office…

The first bioactive compounds were formatted and shipped to our partner sites for COVID-19 related research projects.

The EU-OPENSCREEN compound management team is back in the lab to prepare the bioactive library. The bioactive compounds are needed for COVID-19 research at our screening partner sites.

In response to the SARS-Cov2 pandemic, the Drug Discovery unit of G-INCPM in the Weizmann Institute of Science in Israel, a candidate partner site of EU-OPENSCREEN, underwent significant…

EU-OPENSCREEN is a partner in the recently submitted EUROCOVID “EUROpean COoperation for anti-VIral Drug discovery and preparedness for current and emerging coronavirus outbreaks” Horizon 2020…